Selling Direct
Direct-to-consumer (DTC) drug sales aim to simplify a complex U.S. pharmaceutical system by allowing patients to purchase drugs directly from manufacturers, potentially improving price transparency, convenience and access. Navitus President and Chief Executive Officer, David Fields, notes the state of impact and current share representation of prescriptions.
MORE ABOUT DAVID
David Fields is the President and CEO at Navitus Health Solutions. He provides enterprise leadership and strategic direction for Navitus, collaborating with the executive management team to maintain the overarching strategic plan and to develop and direct its goals, policies and execution. David has held leadership positions on a number of boards, including the American Heart Association, American Red Cross, Labor-Management Council and the National Conference of Christians and Jews.
Stay Informed and Connected
Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.
CLARITY FOR ACTION
Gain Clarity: Navitus 10th Annual Drug Trend Report Ready to Download
Our 2025 report provides transparent, data-driven insight to help plans, plan sponsors and consultants navigate an increasingly complex prescription drug landscape.
Related blogs
Navigating Healthcare and Improving Outcomes
Don’t Sign Here – The 7 Red Flags of PBM Contracts
Signing with a new pharmacy benefit manager (PBM) can be a daunting experience, with hundreds or thousands of plan members depending on that choice. And in this opaque industry, it is important to look beyond the initial conversations with a PBM when…
